LORI MORROW: Open Payments
NPI 1023433232 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$808 in 44 payments from 16 companies in 2025. Trend: 2023 $1,114 · 2024 $968 · 2025 $808
Food & beverage: $808
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $154 |
| PFIZER INC. | 6 | $110 |
| Astellas Pharma US Inc | 4 | $101 |
| Lilly USA, LLC | 5 | $94 |
| Abbott Laboratories | 3 | $63 |
| Dexcom, Inc. | 1 | $41 |
| Organon LLC | 2 | $37 |
| Esperion Therapeutics, Inc. | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Amgen Inc. | 2 | $30 |
Products named: Veozah, Rybelsus, FREESTYLE LIBRE 3, NURTEC ODT, Ozempic, MOUNJARO, JARDIANCE, Dexcom G6 Transmitter.
Industry payments across SC — which companies pay providers there.
